关注
Deyao Li
标题
引用次数
引用次数
年份
Gold-catalyzed conversion of highly strained compounds
D Li, W Zang, MJ Bird, CJT Hyland, M Shi
Chemical Reviews 121 (14), 8685-8755, 2020
972020
EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma
AD Durbin, T Wang, VK Wimalasena, MW Zimmerman, D Li, NV Dharia, ...
Cancer discovery 12 (3), 730-751, 2022
932022
Probing the SAM binding site of SARS-CoV-2 Nsp14 in vitro using SAM competitive inhibitors guides developing selective bisubstrate inhibitors
K Devkota, M Schapira, S Perveen, A Khalili Yazdi, F Li, I Chau, P Ghiabi, ...
SLAS DISCOVERY: Advancing the Science of Drug Discovery 26 (9), 1200-1211, 2021
702021
Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myeloma
Y Song, PMC Park, L Wu, A Ray, S Picaud, D Li, VK Wimalasena, T Du, ...
Leukemia 33 (11), 2685-2694, 2019
472019
Gold (i)-catalyzed cycloisomerization of vinylidenecyclopropane-enes via carbene or non-carbene processes
DY Li, Y Wei, I Marek, XY Tang, M Shi
Chemical Science 6 (10), 5519-5525, 2015
382015
BAF complex maintains glioma stem cells in pediatric H3K27M glioma
E Panditharatna, JG Marques, T Wang, MC Trissal, I Liu, L Jiang, A Beck, ...
Cancer discovery 12 (12), 2880-2905, 2022
312022
Bromodomain protein BRD4 directs and sustains CD8 T cell differentiation during infection
JJ Milner, C Toma, S Quon, K Omilusik, NE Scharping, A Dey, ...
Journal of Experimental Medicine 218 (8), e20202512, 2021
282021
Crystal structure of SARS‐CoV‐2 nsp10–nsp16 in complex with small molecule inhibitors, SS148 and WZ16
M Klima, A Khalili Yazdi, F Li, I Chau, T Hajian, A Bolotokova, ...
Protein Science 31 (9), e4395, 2022
272022
Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma
H Ohguchi, PMC Park, T Wang, BE Gryder, D Ogiya, K Kurata, X Zhang, ...
Blood Cancer discovery 2 (4), 370, 2021
252021
C(sp3)−H Functionalizations Promoted by the Gold Carbene Generated from Vinylidenecyclopropanes
DY Li, W Fang, Y Wei, M Shi
Chemistry–A European Journal 22 (50), 18080-18084, 2016
242016
Development of Dimethylisoxazole-Attached Imidazo[1,2-a]pyridines as Potent and Selective CBP/P300 Inhibitors
A Muthengi, VK Wimalasena, HO Yosief, MJ Bikowitz, LH Sigua, T Wang, ...
Journal of medicinal chemistry 64 (9), 5787-5801, 2021
232021
Synthesis of cyclic and heterocyclic compounds via gold-catalyzed reactions
Q Wang, M Shi
Synlett 28 (17), 2230-2240, 2017
182017
Gold(I)‐Catalyzed Intramolecular Carbon‐Oxygen Bond Cleavage Reaction via Gold Carbenes Derived from Vinylidenecyclopropanes
DY Li, Y Wei, M Shi
Advanced Synthesis & Catalysis 358 (19), 3002-3009, 2016
182016
Grignard Reagent/CuI/LiCl‐Mediated Stereoselective Cascade Addition/Cyclization of Diynes: A Novel Pathway for the Construction of 1‐Methyleneindene Derivatives
DY Li, Y Wei, M Shi
Chemistry–A European Journal 19 (46), 15682-15688, 2013
172013
Ep300 selectively controls the enhancer landscape of MYCN-amplified neuroblastoma. Cancer Discov. 2022; 12: 730–751. doi: 10.1158/2159-8290
AD Durbin, T Wang, VK Wimalasena, MW Zimmerman, D Li, NV Dharia, ...
CD-21-0385.[PMC free article][PubMed][CrossRef][Google Scholar], 0
8
Iron (III)‐Catalyzed 1, 3‐Functional Group Transposition Reactions: Synthetic Protocol to Access 3‐Substituted Indoles
DY Li, Y Wei, M Shi
Asian Journal of Organic Chemistry 5 (3), 423-427, 2016
62016
Gold(I)‐Catalyzed 1,3‐O‐Transposition Reactions: Ynesulfonamides to Ynamides
DY Li, Y Wei, M Shi
European Journal of Organic Chemistry 2015 (19), 4108-4113, 2015
62015
Small molecule target bromo/acetyl proteins and uses thereof
J Qi, D Li, VK Wimalasena, P Park
US Patent App. 17/617,226, 2022
12022
EP300 controls the oncogenic enhancer landscape of high-risk neuroblastoma
AD Durbin, V Wimalasena, MW Zimmerman, L Deyao, ES Frank, P Park, ...
CANCER RESEARCH 80 (14), 37-37, 2020
12020
TARGETED SMALL MOLECULE BROMO/ACETYL PROTEINS AND THEIR USES
J Qi, LI Deyao, VK Wimalasena, P Park
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20